FDA孤儿药物指定-话题@MedSci

#FDA孤儿药物指定#

7篇内容 | 233人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1785986, encodeId=2c1b1e8598637, content=<a href='/topic/show?id=9b61e302f1' target=_blank style='color:#2F92EE;'>#FDA孤儿药物指定#</a>, objectTitle=Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定, objectType=article, longId=182512, objectId=6d2018251202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d2018251202, replyNumber=0, likeNumber=34, createdTime=2020-04-11, rootId=0, userName=huperzia, userId=ca89104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d2018251202, moduleTitle=Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d2018251202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785984, encodeId=efb41e8598421, content=<a href='/topic/show?id=9b61e302f1' target=_blank style='color:#2F92EE;'>#FDA孤儿药物指定#</a>, objectTitle=中心核肌病反义核酸药物DYN101获得FDA孤儿药物指定, objectType=article, longId=177565, objectId=653d1e756528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=653d1e756528, replyNumber=0, likeNumber=33, createdTime=2019-08-17, rootId=0, userName=huperzia, userId=ca89104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=653d1e756528, moduleTitle=中心核肌病反义核酸药物DYN101获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=653d1e756528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785982, encodeId=d0951e8598256, content=<a href='/topic/show?id=9b61e302f1' target=_blank style='color:#2F92EE;'>#FDA孤儿药物指定#</a>, objectTitle=Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定, objectType=article, longId=161780, objectId=3be5161e8072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be5161e8072, replyNumber=0, likeNumber=33, createdTime=2019-04-21, rootId=0, userName=huperzia, userId=ca89104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be5161e8072, moduleTitle=Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be5161e8072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785985, encodeId=eb551e8598540, content=<a href='/topic/show?id=9b61e302f1' target=_blank style='color:#2F92EE;'>#FDA孤儿药物指定#</a>, objectTitle=Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定, objectType=article, longId=179623, objectId=75b91e96234a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75b91e96234a, replyNumber=0, likeNumber=32, createdTime=2020-06-12, rootId=0, userName=huperzia, userId=ca89104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75b91e96234a, moduleTitle=Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75b91e96234a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785983, encodeId=0b661e859833e, content=<a href='/topic/show?id=9b61e302f1' target=_blank style='color:#2F92EE;'>#FDA孤儿药物指定#</a>, objectTitle=Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定, objectType=article, longId=162178, objectId=41161621e864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41161621e864, replyNumber=0, likeNumber=18, createdTime=2019-06-16, rootId=0, userName=huperzia, userId=ca89104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41161621e864, moduleTitle=Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41161621e864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785981, encodeId=9ef71e85981a4, content=<a href='/topic/show?id=9b61e302f1' target=_blank style='color:#2F92EE;'>#FDA孤儿药物指定#</a>, objectTitle=MB-102（CD123 CAR T）获得FDA孤儿药物指定用于治疗浆细胞样树突状细胞肿瘤, objectType=article, longId=156453, objectId=e4e31564538b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4e31564538b, replyNumber=0, likeNumber=35, createdTime=2019-06-05, rootId=0, userName=huperzia, userId=ca89104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4e31564538b, moduleTitle=MB-102（CD123 CAR T）获得FDA孤儿药物指定用于治疗浆细胞样树突状细胞肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4e31564538b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785980, encodeId=a41b1e85980e6, content=<a href='/topic/show?id=9b61e302f1' target=_blank style='color:#2F92EE;'>#FDA孤儿药物指定#</a>, objectTitle=Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定, objectType=article, longId=149700, objectId=ed23149e009d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed23149e009d, replyNumber=0, likeNumber=36, createdTime=2019-07-26, rootId=0, userName=huperzia, userId=ca89104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed23149e009d, moduleTitle=Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed23149e009d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FDA孤儿药物指定

2020-05-29

huperzia (审核中...)

前往app查看评论内容

#FDA孤儿药物指定#

Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定

2020-04-11

huperzia (审核中...)

前往app查看评论内容

#FDA孤儿药物指定#

中心核肌病反义核酸药物DYN101获得FDA孤儿药物指定

2019-08-17

huperzia (审核中...)

前往app查看评论内容

#FDA孤儿药物指定#

Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定

2019-04-21

huperzia (审核中...)

前往app查看评论内容

#FDA孤儿药物指定#

Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定

2020-06-12

huperzia (审核中...)

前往app查看评论内容

#FDA孤儿药物指定#

Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定

2019-06-16

huperzia (审核中...)

前往app查看评论内容

#FDA孤儿药物指定#

MB-102（CD123 CAR T）获得FDA孤儿药物指定用于治疗浆细胞样树突状细胞肿瘤

2019-06-05

huperzia (审核中...)

前往app查看评论内容

#FDA孤儿药物指定#

Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定

2019-07-26

科室
- - 订阅+
  - 更多科室
工具
服务